ADPT
Price
$7.64
Change
+$0.26 (+3.52%)
Updated
Apr 24, 02:15 PM (EDT)
Capitalization
1.04B
7 days until earnings call
TECH
Price
$50.59
Change
+$0.42 (+0.84%)
Updated
Apr 24, 11:34 AM (EDT)
Capitalization
7.76B
13 days until earnings call
Ad is loading...

ADPT vs TECH

Header iconADPT vs TECH Comparison
Open Charts ADPT vs TECHBanner chart's image
Adaptive Biotechnologies
Price$7.64
Change+$0.26 (+3.52%)
Volume$300
Capitalization1.04B
Bio-Techne
Price$50.59
Change+$0.42 (+0.84%)
Volume$1.05K
Capitalization7.76B
ADPT vs TECH Comparison Chart
Loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADPT vs. TECH commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a Hold and TECH is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (ADPT: $7.36 vs. TECH: $50.16)
Brand notoriety: ADPT: Notable vs. TECH: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADPT: 87% vs. TECH: 84%
Market capitalization -- ADPT: $1.04B vs. TECH: $7.76B
ADPT [@Biotechnology] is valued at $1.04B. TECH’s [@Biotechnology] market capitalization is $7.76B. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADPT’s FA Score shows that 0 FA rating(s) are green whileTECH’s FA Score has 1 green FA rating(s).

  • ADPT’s FA Score: 0 green, 5 red.
  • TECH’s FA Score: 1 green, 4 red.
According to our system of comparison, TECH is a better buy in the long-term than ADPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADPT’s TA Score shows that 3 TA indicator(s) are bullish while TECH’s TA Score has 6 bullish TA indicator(s).

  • ADPT’s TA Score: 3 bullish, 6 bearish.
  • TECH’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, TECH is a better buy in the short-term than ADPT.

Price Growth

ADPT (@Biotechnology) experienced а -1.74% price change this week, while TECH (@Biotechnology) price change was +0.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.97%. For the same industry, the average monthly price growth was -6.11%, and the average quarterly price growth was -12.33%.

Reported Earning Dates

ADPT is expected to report earnings on Jul 30, 2025.

TECH is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+6.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECH($7.76B) has a higher market cap than ADPT($1.04B). ADPT YTD gains are higher at: 22.769 vs. TECH (-30.279). TECH has higher annual earnings (EBITDA): 307M vs. ADPT (-128.76M). ADPT has more cash in the bank: 222M vs. TECH (178M). ADPT has less debt than TECH: ADPT (89.4M) vs TECH (395M). TECH has higher revenues than ADPT: TECH (1.2B) vs ADPT (179M).
ADPTTECHADPT / TECH
Capitalization1.04B7.76B13%
EBITDA-128.76M307M-42%
Gain YTD22.769-30.279-75%
P/E RatioN/A50.08-
Revenue179M1.2B15%
Total Cash222M178M125%
Total Debt89.4M395M23%
FUNDAMENTALS RATINGS
ADPT vs TECH: Fundamental Ratings
ADPT
TECH
OUTLOOK RATING
1..100
6565
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
3
Undervalued
PROFIT vs RISK RATING
1..100
10091
SMR RATING
1..100
9578
PRICE GROWTH RATING
1..100
3865
P/E GROWTH RATING
1..100
10035
SEASONALITY SCORE
1..100
n/a65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECH's Valuation (3) in the Biotechnology industry is somewhat better than the same rating for ADPT (55) in the Hospital Or Nursing Management industry. This means that TECH’s stock grew somewhat faster than ADPT’s over the last 12 months.

TECH's Profit vs Risk Rating (91) in the Biotechnology industry is in the same range as ADPT (100) in the Hospital Or Nursing Management industry. This means that TECH’s stock grew similarly to ADPT’s over the last 12 months.

TECH's SMR Rating (78) in the Biotechnology industry is in the same range as ADPT (95) in the Hospital Or Nursing Management industry. This means that TECH’s stock grew similarly to ADPT’s over the last 12 months.

ADPT's Price Growth Rating (38) in the Hospital Or Nursing Management industry is in the same range as TECH (65) in the Biotechnology industry. This means that ADPT’s stock grew similarly to TECH’s over the last 12 months.

TECH's P/E Growth Rating (35) in the Biotechnology industry is somewhat better than the same rating for ADPT (100) in the Hospital Or Nursing Management industry. This means that TECH’s stock grew somewhat faster than ADPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADPTTECH
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
69%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
70%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 1 day ago
73%
View a ticker or compare two or three
Ad is loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PHK4.660.07
+1.41%
PIMCO High Income Fund
PSF19.150.17
+0.90%
COHEN & STEERS SELECT PREFERRED AND Income FUND
GDO11.170.09
+0.83%
Western Asset Global Corporate Opportunity Fund Inc
BBCA72.850.20
+0.28%
JPMorgan BetaBuilders Canada ETF
RINF32.690.08
+0.24%
ProShares Inflation Expectations

ADPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADPT has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ADPT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADPT
1D Price
Change %
ADPT100%
+4.99%
AXON - ADPT
56%
Loosely correlated
+3.82%
VCYT - ADPT
54%
Loosely correlated
+1.08%
BEAM - ADPT
51%
Loosely correlated
+3.87%
ARRY - ADPT
50%
Loosely correlated
+0.93%
ABCL - ADPT
50%
Loosely correlated
+0.79%
More